The goal of this clinical trial is to test the safety and effectiveness of an injection study drug in decreasing bilateral flank adiposity. The main question it aims to answer is: •How safe and effective is the injection study drug in removing bilateral flank adiposity compared to a placebo? Participants will be: * Be given injections every month for 5 months over the right and left flanks. * Be asked to be seen in the clinic for 13 visits and 3 phone call visits during a duration of 1 year.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Volumetric measurements
Timeframe: 24 weeks after final injection treatment
Flank Skin Laxity Scale (FSLS)
Timeframe: 24 weeks after final injection treatment
Clinician Global Impression of Change (CGIC)
Timeframe: 24 weeks after final injection treatment
Patient Global Impression of Change (PGIC)
Timeframe: 24 weeks after final injection treatment